Burning Rock Biotech
D

BNR

13.040
USD
0.38
(3.00%)
Market Closed
Last updated: · Delayed 15 min
Volume
400
EPS
0
Div Yield
-
P/E
-16
Market Cap
137,524,313

Title: Burning Rock Biotech Limited

Sector: Healthcare
Industry: Diagnostics & Research
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreementswith the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

Common questions about Burning Rock Biotech stock